Aplikace z oblasti Farmaceutická analýza od Waters - strana 4
Otevřít dokument Enhanced Risk Assessment for a Traditional LC Separation Method Using ICH Q14 Regulatory Principles and a Simplified HPLC System
LCMS
Enhanced Risk Assessment for a Traditional LC Separation Method Using ICH Q14 Regulatory Principles and a Simplified HPLC System
HPLC
Instrumentace
HPLC
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Walk-up Mass Confirmation of Glucagon-like Peptides (GLP-1) Using the Xevo™ G3 QTof Combined with RemoteAnalyzer® Open Access Software
LCMS
Walk-up Mass Confirmation of Glucagon-like Peptides (GLP-1) Using the Xevo™ G3 QTof Combined with RemoteAnalyzer® Open Access Software
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Characterizing “nature’s Ozempic ”: Non-targeted screening of berberine supplements using ion mobility high-resolution mass spectrometry
LCMS
Characterizing “nature’s Ozempic ”: Non-targeted screening of berberine supplements using ion mobility high-resolution mass spectrometry
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Iontová mobilita
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Iontová mobilita
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Determination of Fatty Acid Composition in Polysorbate 80 using HPLC with Charged Aerosol Detection
LCMS
Determination of Fatty Acid Composition in Polysorbate 80 using HPLC with Charged Aerosol Detection
HPLC
Instrumentace
HPLC
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Multipass Ion Mobility Separation of GLP-1 Receptor Agonist Impurities Using the SELECT SERIES™ Cyclic™ IMS
LCMS
Multipass Ion Mobility Separation of GLP-1 Receptor Agonist Impurities Using the SELECT SERIES™ Cyclic™ IMS
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Iontová mobilita
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Iontová mobilita
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Investigating the Strength of the Sense and Antisense Oligonucleotide Interaction to Form siRNA Duplexes Using the BioAccord™ LC-MS System
LCMS
Investigating the Strength of the Sense and Antisense Oligonucleotide Interaction to Form siRNA Duplexes Using the BioAccord™ LC-MS System
LC/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument LC-MS Analysis of Two mRNA Critical Quality Attributes: 5’-Capping Efficiency and Average Poly(A) Tail Length and Heterogeneity Using the Xevo™ MRT Mass Spectrometer
LCMS
LC-MS Analysis of Two mRNA Critical Quality Attributes: 5’-Capping Efficiency and Average Poly(A) Tail Length and Heterogeneity Using the Xevo™ MRT Mass Spectrometer
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Software
Instrumentace
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Software
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Enabling Reliable Heparin Sodium Nucleotidic Impurity Analysis with the Alliance™ iS Bio HPLC System with PDA Detector
LCMS
Enabling Reliable Heparin Sodium Nucleotidic Impurity Analysis with the Alliance™ iS Bio HPLC System with PDA Detector
HPLC
Instrumentace
HPLC
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
LCMS
Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Quantitation of N-Nitroso-Desmethyl- Diltiazem, an NDSRI Impurity of Diltiazem Hydrochloride in Drug Product Using LCMS/ MS
LCMS
Quantitation of N-Nitroso-Desmethyl- Diltiazem, an NDSRI Impurity of Diltiazem Hydrochloride in Drug Product Using LCMS/ MS
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Waters
Zaměření
Farmaceutická analýza
